Dr. Alberto Ardura-Fabregat Named 2026 Shelanski Research Innovation Award Recipient
The Department of Pathology and Cell Biology is pleased to announce that Dr. Alberto Ardura-Fabregat, MD, PhD, PGY3 resident, has been selected as the recipient of the 2026 Shelanski Research Innovation Award in Pathology for the research proposal titled “Rethinking Mitochondrial Leukoencephalopathies: Interferon-Dominant Glial Pathobiology in mtDNA Instability Disorders.”
Supported by generous gifts from the Ralph Abrams Fund and the Herman Shelanski Memorial Fund, this competitive award supports the development of innovative research ideas and concepts proposed by fellows and residents within the Department of Pathology and Cell Biology.
Please join us in congratulating Dr. Ardura-Fabregat on this well-deserved recognition. We look forward to the exciting contributions this research will bring to the field!
Previous awardees:
2017 - Osama Al Dalahmah, proposal titled: Glial Heterogeneity in Health and Huntington’s Disease.
2018 - Paul (Chun Chieh) Lin, proposal titled: Deciphering Multifactorial Genetic Contributions for Motor Neuron Development.
2020 - Marie Smithgall, proposal titled: Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers.
2021 - Michael Miller, proposal titled: Rosette-forming Glioneuronal Tumors (RGNT) Are Rare Brain Tumors Primarily Seen in Children And Young Adults.
2022 - Yu Sun, proposal titled: Dissecting IDH-mutant dependence and intratumor heterogeneity during astrocytoma progression.